{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_48753"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_48753","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"Biocatalysis of aromatic [beta]-hydroxy-[alpha]-amino acids via regio- and stereoselective amination of trans-3-arylglycidates using a phenylalanine aminomutase","abstract":"Biocatalytic process-development continues to advance toward discovering alternative transformation reactions to synthesize medicinally important molecules such as, β-hydroxy-α-amino acids. These bifunctional building blocks, a subclass of noncanonical amino acids, have two stereocenters and are valuable in the natural product, pharmaceutical, and agrochemical sectors.Here, a 5-methylidene-3,5-dihydro-4H-imidazol-4-one (MIO)-dependent phenylalanine aminomutase from Taxus canadensis (TcPAM) was repurposed to irreversibly biocatalyze an intermolecular amino group transfer regioselectively from (2S)-styryl-α-alanine to ring-substituted racemic trans-3-arylglycidates (i.e., cinnamate epoxides) to make the corresponding arylserines. The reaction scope of MIO-aminomutases, which primarily catalyze the reversible interconversion of α- and β-amino acids, can also catalyze the hydroamination of arylacrylates to form α- and β-amino acids. Here, we explore glycidates as a new class of substrates for the MIO-aminomutase family of enzymes. Racemic trans-3-arylglycidates were regio- and stereoselectively aminated to produce a mixture of anti-arylserine enantiomers predominantly. 3-Arylglycidates usually prefer nucleophilic attack at the benzylic Cβ due to stabilization of the partial cationic properties (δ+) at the Cβ by the aryl ring, a stabilization that does not occur at Cα. TcPAM catalysis, however, inverted this inherent nucleophilic regioselectivity by aminating at the Cα of trans-3-arylglycidates to make arylserine predominantly (97%) over arylisoserine (3%). From among twelve substrates, the aminomutase ring-opened 3'-Cl-phenylglycidate to 3'-Cl-phenylserine 140 times faster than it opened the 4'-Cl-isomer, which was turned over slowest among all epoxides tested. GC/MS analysis of chiral auxiliary derivatives of the biocatalyzed arylserine analogues showed that each product mixture contained (2S)+(2R)-anti and (2S)+(2R)-syn pairs with the anti-isomers predominating (~90:10 dr). Integrating the vicinal proton signals in the 1H-NMR spectrum of the biocatalyzed arylserines and calculating the chemical shift difference (Δδ) between the anti and syn proton signals confirmed the diastereomeric ratios and relative stereochemistries. Application of a (2S)-threonine aldolase from E. coli further established the absolute stereochemistry of the chiral derivatives of the diastereomeric biocatalyzed products. The 2R:2S ratio for the biocatalyzed anti-isomers was highest (88:12) for 3'-NO2-phenylserine and lowest (66:34) for 4'-F-phenylserine. This showed that the stereospecificity of TcPAM is, in part, directed by the substituent-type on the arylglycidate analogue.We also synthesized enantiopure 3-phenylglycidates and incubated them separately with TcPAM. The absolute configurations of the biocatalyzed anti-phenylserine (major) and phenylisoserine (minor) were evaluated to gain insights on the substrate specificity and selectivity of TcPAM for aminating 3-phenylglycidate enantiomers. TcPAM converted (2S,3R)-3-phenylglycidate to (2S)-anti-phenylserine predominantly (89%) and (2R,3S)-3-phenylglycidate to (2R)-anti-phenylserine (88%) over their antipodes with inversion of configuration at Cα in each case. Both glycidate enantiomers formed a small amount (~10%) of the syn-phenylserine with retention of configuration at the Cα. TcPAM had a slight preference toward (2S,3R)-3-phenylglycidate, which was turned over (k_cat = 0.3 min-1) 1.5 times faster than the (2R,3S)-glycidate (k_cat = 0.2 min-1). The kinetics data showed that the amination of arylglycidate process follows a two-substrate ping-pong mechanism with competitive inhibition by the epoxide substrate at higher concentration.","abstract_html":"Biocatalytic process-development continues to advance toward discovering alternative transformation reactions to synthesize medicinally important molecules such as, β-hydroxy-α-amino acids. These bifunctional building blocks, a subclass of noncanonical amino acids, have two stereocenters and are valuable in the natural product, pharmaceutical, and agrochemical sectors.Here, a 5-methylidene-3,5-dihydro-4H-imidazol-4-one (MIO)-dependent phenylalanine aminomutase from Taxus canadensis (TcPAM) was repurposed to irreversibly biocatalyze an intermolecular amino group transfer regioselectively from (2S)-styryl-α-alanine to ring-substituted racemic trans-3-arylglycidates (i.e., cinnamate epoxides) to make the corresponding arylserines. The reaction scope of MIO-aminomutases, which primarily catalyze the reversible interconversion of α- and β-amino acids, can also catalyze the hydroamination of arylacrylates to form α- and β-amino acids. Here, we explore glycidates as a new class of substrates for the MIO-aminomutase family of enzymes. Racemic trans-3-arylglycidates were regio- and stereoselectively aminated to produce a mixture of anti-arylserine enantiomers predominantly. 3-Arylglycidates usually prefer nucleophilic attack at the benzylic Cβ due to stabilization of the partial cationic properties (δ+) at the Cβ by the aryl ring, a stabilization that does not occur at Cα. TcPAM catalysis, however, inverted this inherent nucleophilic regioselectivity by aminating at the Cα of trans-3-arylglycidates to make arylserine predominantly (97%) over arylisoserine (3%). From among twelve substrates, the aminomutase ring-opened 3&#x27;-Cl-phenylglycidate to 3&#x27;-Cl-phenylserine 140 times faster than it opened the 4&#x27;-Cl-isomer, which was turned over slowest among all epoxides tested. GC/MS analysis of chiral auxiliary derivatives of the biocatalyzed arylserine analogues showed that each product mixture contained (2S)+(2R)-anti and (2S)+(2R)-syn pairs with the anti-isomers predominating (~90:10 dr). Integrating the vicinal proton signals in the 1H-NMR spectrum of the biocatalyzed arylserines and calculating the chemical shift difference (Δδ) between the anti and syn proton signals confirmed the diastereomeric ratios and relative stereochemistries. Application of a (2S)-threonine aldolase from E. coli further established the absolute stereochemistry of the chiral derivatives of the diastereomeric biocatalyzed products. The 2R:2S ratio for the biocatalyzed anti-isomers was highest (88:12) for 3&#x27;-NO2-phenylserine and lowest (66:34) for 4&#x27;-F-phenylserine. This showed that the stereospecificity of TcPAM is, in part, directed by the substituent-type on the arylglycidate analogue.We also synthesized enantiopure 3-phenylglycidates and incubated them separately with TcPAM. The absolute configurations of the biocatalyzed anti-phenylserine (major) and phenylisoserine (minor) were evaluated to gain insights on the substrate specificity and selectivity of TcPAM for aminating 3-phenylglycidate enantiomers. TcPAM converted (2S,3R)-3-phenylglycidate to (2S)-anti-phenylserine predominantly (89%) and (2R,3S)-3-phenylglycidate to (2R)-anti-phenylserine (88%) over their antipodes with inversion of configuration at Cα in each case. Both glycidate enantiomers formed a small amount (~10%) of the syn-phenylserine with retention of configuration at the Cα. TcPAM had a slight preference toward (2S,3R)-3-phenylglycidate, which was turned over (k_cat = 0.3 min-1) 1.5 times faster than the (2R,3S)-glycidate (k_cat = 0.2 min-1). The kinetics data showed that the amination of arylglycidate process follows a two-substrate ping-pong mechanism with competitive inhibition by the epoxide substrate at higher concentration.","abstract_has_math":false,"creators":["Shee, Prakash Kumar"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Walker, Kevin D.","Huang, Xuefei","Frost, John W.","Blanchard, Gary J."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2020,"date_issued":"2020","date_published":"2020","updated_at":"2026-11-18T18:53:51Z","subjects":["Biocatalysis","Drugs--Synthesis"],"languages":["English"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:48753","isbn:9798664735192","oclc:1201189893","umi:28086396","local:Shee_grad.msu_0128D_17783"],"render_values":[{"text":"etd:48753","href":null,"code":true},{"text":"isbn:9798664735192","href":null,"code":true},{"text":"oclc:1201189893","href":null,"code":true},{"text":"umi:28086396","href":null,"code":true},{"text":"local:Shee_grad.msu_0128D_17783","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/k9gz-fk21","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/k9gz-fk21","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_48753","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Walker, Kevin D.","Huang, Xuefei","Frost, John W.","Blanchard, Gary J."]},{"key":"dc:creator","label":"Author","values":["Shee, Prakash Kumar"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2020"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["Text","Theses"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biocatalysis","Drugs--Synthesis"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:48753","isbn:9798664735192","oclc:1201189893","umi:28086396","local:Shee_grad.msu_0128D_17783","https://doi.org/doi:10.25335/k9gz-fk21"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Biocatalytic process-development continues to advance toward discovering alternative transformation reactions to synthesize medicinally important molecules such as, β-hydroxy-α-amino acids. These bifunctional building blocks, a subclass of noncanonical amino acids, have two stereocenters and are valuable in the natural product, pharmaceutical, and agrochemical sectors.Here, a 5-methylidene-3,5-dihydro-4H-imidazol-4-one (MIO)-dependent phenylalanine aminomutase from Taxus canadensis (TcPAM) was repurposed to irreversibly biocatalyze an intermolecular amino group transfer regioselectively from (2S)-styryl-α-alanine to ring-substituted racemic trans-3-arylglycidates (i.e., cinnamate epoxides) to make the corresponding arylserines. The reaction scope of MIO-aminomutases, which primarily catalyze the reversible interconversion of α- and β-amino acids, can also catalyze the hydroamination of arylacrylates to form α- and β-amino acids. Here, we explore glycidates as a new class of substrates for the MIO-aminomutase family of enzymes. Racemic trans-3-arylglycidates were regio- and stereoselectively aminated to produce a mixture of anti-arylserine enantiomers predominantly. 3-Arylglycidates usually prefer nucleophilic attack at the benzylic Cβ due to stabilization of the partial cationic properties (δ+) at the Cβ by the aryl ring, a stabilization that does not occur at Cα. TcPAM catalysis, however, inverted this inherent nucleophilic regioselectivity by aminating at the Cα of trans-3-arylglycidates to make arylserine predominantly (97%) over arylisoserine (3%). From among twelve substrates, the aminomutase ring-opened 3'-Cl-phenylglycidate to 3'-Cl-phenylserine 140 times faster than it opened the 4'-Cl-isomer, which was turned over slowest among all epoxides tested. GC/MS analysis of chiral auxiliary derivatives of the biocatalyzed arylserine analogues showed that each product mixture contained (2S)+(2R)-anti and (2S)+(2R)-syn pairs with the anti-isomers predominating (~90:10 dr). Integrating the vicinal proton signals in the 1H-NMR spectrum of the biocatalyzed arylserines and calculating the chemical shift difference (Δδ) between the anti and syn proton signals confirmed the diastereomeric ratios and relative stereochemistries. Application of a (2S)-threonine aldolase from E. coli further established the absolute stereochemistry of the chiral derivatives of the diastereomeric biocatalyzed products. The 2R:2S ratio for the biocatalyzed anti-isomers was highest (88:12) for 3'-NO2-phenylserine and lowest (66:34) for 4'-F-phenylserine. This showed that the stereospecificity of TcPAM is, in part, directed by the substituent-type on the arylglycidate analogue.We also synthesized enantiopure 3-phenylglycidates and incubated them separately with TcPAM. The absolute configurations of the biocatalyzed anti-phenylserine (major) and phenylisoserine (minor) were evaluated to gain insights on the substrate specificity and selectivity of TcPAM for aminating 3-phenylglycidate enantiomers. TcPAM converted (2S,3R)-3-phenylglycidate to (2S)-anti-phenylserine predominantly (89%) and (2R,3S)-3-phenylglycidate to (2R)-anti-phenylserine (88%) over their antipodes with inversion of configuration at Cα in each case. Both glycidate enantiomers formed a small amount (~10%) of the syn-phenylserine with retention of configuration at the Cα. TcPAM had a slight preference toward (2S,3R)-3-phenylglycidate, which was turned over (k_cat = 0.3 min-1) 1.5 times faster than the (2R,3S)-glycidate (k_cat = 0.2 min-1). The kinetics data showed that the amination of arylglycidate process follows a two-substrate ping-pong mechanism with competitive inhibition by the epoxide substrate at higher concentration.","Thesis (Ph. D.)--Michigan State University. Chemistry, 2020","Includes bibliographical references"]},{"key":"dc:format","label":"Dc Format","values":["xxix, 194 pages","application/pdf"]},{"key":"dc:title","label":"Title","values":["Biocatalysis of aromatic [beta]-hydroxy-[alpha]-amino acids via regio- and stereoselective amination of trans-3-arylglycidates using a phenylalanine aminomutase"]}]}],"canonical_facts":{"dc:contributor":["Walker, Kevin D.","Huang, Xuefei","Frost, John W.","Blanchard, Gary J."],"dc:creator":["Shee, Prakash Kumar"],"dc:date":["2020"],"dc:description":["Biocatalytic process-development continues to advance toward discovering alternative transformation reactions to synthesize medicinally important molecules such as, β-hydroxy-α-amino acids. These bifunctional building blocks, a subclass of noncanonical amino acids, have two stereocenters and are valuable in the natural product, pharmaceutical, and agrochemical sectors.Here, a 5-methylidene-3,5-dihydro-4H-imidazol-4-one (MIO)-dependent phenylalanine aminomutase from Taxus canadensis (TcPAM) was repurposed to irreversibly biocatalyze an intermolecular amino group transfer regioselectively from (2S)-styryl-α-alanine to ring-substituted racemic trans-3-arylglycidates (i.e., cinnamate epoxides) to make the corresponding arylserines. The reaction scope of MIO-aminomutases, which primarily catalyze the reversible interconversion of α- and β-amino acids, can also catalyze the hydroamination of arylacrylates to form α- and β-amino acids. Here, we explore glycidates as a new class of substrates for the MIO-aminomutase family of enzymes. Racemic trans-3-arylglycidates were regio- and stereoselectively aminated to produce a mixture of anti-arylserine enantiomers predominantly. 3-Arylglycidates usually prefer nucleophilic attack at the benzylic Cβ due to stabilization of the partial cationic properties (δ+) at the Cβ by the aryl ring, a stabilization that does not occur at Cα. TcPAM catalysis, however, inverted this inherent nucleophilic regioselectivity by aminating at the Cα of trans-3-arylglycidates to make arylserine predominantly (97%) over arylisoserine (3%). From among twelve substrates, the aminomutase ring-opened 3'-Cl-phenylglycidate to 3'-Cl-phenylserine 140 times faster than it opened the 4'-Cl-isomer, which was turned over slowest among all epoxides tested. GC/MS analysis of chiral auxiliary derivatives of the biocatalyzed arylserine analogues showed that each product mixture contained (2S)+(2R)-anti and (2S)+(2R)-syn pairs with the anti-isomers predominating (~90:10 dr). Integrating the vicinal proton signals in the 1H-NMR spectrum of the biocatalyzed arylserines and calculating the chemical shift difference (Δδ) between the anti and syn proton signals confirmed the diastereomeric ratios and relative stereochemistries. Application of a (2S)-threonine aldolase from E. coli further established the absolute stereochemistry of the chiral derivatives of the diastereomeric biocatalyzed products. The 2R:2S ratio for the biocatalyzed anti-isomers was highest (88:12) for 3'-NO2-phenylserine and lowest (66:34) for 4'-F-phenylserine. This showed that the stereospecificity of TcPAM is, in part, directed by the substituent-type on the arylglycidate analogue.We also synthesized enantiopure 3-phenylglycidates and incubated them separately with TcPAM. The absolute configurations of the biocatalyzed anti-phenylserine (major) and phenylisoserine (minor) were evaluated to gain insights on the substrate specificity and selectivity of TcPAM for aminating 3-phenylglycidate enantiomers. TcPAM converted (2S,3R)-3-phenylglycidate to (2S)-anti-phenylserine predominantly (89%) and (2R,3S)-3-phenylglycidate to (2R)-anti-phenylserine (88%) over their antipodes with inversion of configuration at Cα in each case. Both glycidate enantiomers formed a small amount (~10%) of the syn-phenylserine with retention of configuration at the Cα. TcPAM had a slight preference toward (2S,3R)-3-phenylglycidate, which was turned over (k_cat = 0.3 min-1) 1.5 times faster than the (2R,3S)-glycidate (k_cat = 0.2 min-1). The kinetics data showed that the amination of arylglycidate process follows a two-substrate ping-pong mechanism with competitive inhibition by the epoxide substrate at higher concentration.","Thesis (Ph. D.)--Michigan State University. Chemistry, 2020","Includes bibliographical references"],"dc:format":["xxix, 194 pages","application/pdf"],"dc:identifier":["etd:48753","isbn:9798664735192","oclc:1201189893","umi:28086396","local:Shee_grad.msu_0128D_17783","https://doi.org/doi:10.25335/k9gz-fk21"],"dc:language":["English"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["In Copyright"],"dc:subject":["Biocatalysis","Drugs--Synthesis"],"dc:title":["Biocatalysis of aromatic [beta]-hydroxy-[alpha]-amino acids via regio- and stereoselective amination of trans-3-arylglycidates using a phenylalanine aminomutase"],"dc:type":["Text","Theses"]},"updated_at":"2026-11-18T18:53:51Z"}